Neurocrine Biosciences (NBIX) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Neurocrine Biosciences Revenue Highlights

Latest Revenue (Y)

$1.89B

Latest Revenue (Q)

$622.10M

Main Segment (Y)

Product

Neurocrine Biosciences Revenue by Period

Neurocrine Biosciences Revenue by Year

Date	Revenue	Change
2023-12-31	$1.89B	26.76%
2022-12-31	$1.49B	31.34%
2021-12-31	$1.13B	8.38%
2020-12-31	$1.05B	32.71%
2019-12-31	$788.10M	74.65%
2018-12-31	$451.24M	179.19%
2017-12-31	$161.63M	977.51%
2016-12-31	$15.00M	-24.12%
2015-12-31	$19.77M	100.00%
2014-12-31	-	-100.00%
2013-12-31	$2.92M	-94.51%
2012-12-31	$53.14M	-31.36%
2011-12-31	$77.41M	131.08%
2010-12-31	$33.50M	1034.47%
2009-12-31	$2.95M	-25.71%
2008-12-31	$3.98M	224.75%
2007-12-31	$1.22M	-96.88%
2006-12-31	$39.23M	-68.33%
2005-12-31	$123.89M	45.45%
2004-12-31	$85.18M	-38.76%
2003-12-31	$139.08M	670.73%
2002-12-31	$18.05M	-56.25%
2001-12-31	$41.24M	182.71%
2000-12-31	$14.59M	-13.17%
1999-12-31	$16.80M	5.00%
1998-12-31	$16.00M	-38.70%
1997-12-31	$26.10M	35.94%
1996-12-31	$19.20M	-

Neurocrine Biosciences generated $1.89B in revenue during NA 2023, up 26.76% compared to the previous quarter, and up 418.20% compared to the same period a year ago.

Neurocrine Biosciences Revenue by Quarter

Date	Revenue	Change
2024-09-30	$622.10M	5.40%
2024-06-30	$590.20M	14.54%
2024-03-31	$515.30M	0.02%
2023-12-31	$515.20M	3.29%
2023-09-30	$498.80M	10.18%
2023-06-30	$452.70M	7.68%
2023-03-31	$420.40M	2.04%
2022-12-31	$412.00M	6.21%
2022-09-30	$387.90M	2.56%
2022-06-30	$378.20M	21.76%
2022-03-31	$310.60M	-0.45%
2021-12-31	$312.00M	5.41%
2021-09-30	$296.00M	2.46%
2021-06-30	$288.90M	22.10%
2021-03-31	$236.60M	-4.56%
2020-12-31	$247.90M	-4.10%
2020-09-30	$258.50M	-14.52%
2020-06-30	$302.40M	27.54%
2020-03-31	$237.10M	-2.87%
2019-12-31	$244.10M	9.91%
2019-09-30	$222.09M	20.98%
2019-06-30	$183.58M	32.64%
2019-03-31	$138.40M	5.26%
2018-12-31	$131.49M	-13.35%
2018-09-30	$151.76M	56.60%
2018-06-30	$96.91M	36.32%
2018-03-31	$71.09M	-24.79%
2017-12-31	$94.52M	55.52%
2017-09-30	$60.77M	859.34%
2017-06-30	$6.33M	100.00%
2017-03-31	-	100.00%
2016-12-31	-	100.00%
2016-09-30	-	100.00%
2016-06-30	-	-100.00%
2016-03-31	$15.00M	100.00%
2015-12-31	-	100.00%
2015-09-30	-	100.00%
2015-06-30	-	-100.00%
2015-03-31	$19.77M	100.00%
2014-12-31	-	100.00%
2014-09-30	-	100.00%
2014-06-30	-	100.00%
2014-03-31	-	-100.00%
2013-12-31	$730.00K	0.14%
2013-09-30	$729.00K	-0.14%
2013-06-30	$730.00K	-
2013-03-31	$730.00K	-96.67%
2012-12-31	$21.95M	134.55%
2012-09-30	$9.36M	-11.47%
2012-06-30	$10.57M	-6.20%
2012-03-31	$11.27M	1.41%
2011-12-31	$11.11M	-73.32%
2011-09-30	$41.63M	242.47%
2011-06-30	$12.16M	-2.84%
2011-03-31	$12.51M	-8.38%
2010-12-31	$13.66M	-5.47%
2010-09-30	$14.45M	211.18%
2010-06-30	$4.64M	516.60%
2010-03-31	$753.00K	1.76%
2009-12-31	$740.00K	0.95%
2009-09-30	$733.00K	-
2009-06-30	$733.00K	-1.87%
2009-03-31	$747.00K	2.47%
2008-12-31	$729.00K	-4.20%
2008-09-30	$761.00K	3.68%
2008-06-30	$734.00K	-58.08%
2008-03-31	$1.75M	-

Neurocrine Biosciences generated $622.10M in revenue during Q3 2024, up 5.40% compared to the previous quarter, and up 137.42% compared to the same period a year ago.

Neurocrine Biosciences Revenue Breakdown

Neurocrine Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Product	$1.86B	$1.44B	$1.09B	$994.10M	$752.90M
Collaboration Revenue	$26.50M	$47.80M	$43.40M	$51.80M	$35.19M

Neurocrine Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (98.60%), and Collaboration Revenue (1.40%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Product	$616.60M	$583.80M	$509.00M	$507.20M	$491.80M	$446.30M	$415.30M	$404.60M	$379.30M	$352.00M	$305.00M	$303.50M	$288.80M	$231.00M	$241.30M	$254.10M	$267.60M	$231.10M	$237.83M	-
Collaboration Revenue	$5.50M	$6.40M	$6.30M	$8.00M	$7.00M	$6.40M	$5.10M	$7.40M	$8.60M	$26.20M	$5.60M	$8.50M	$7.20M	$22.10M	$5.60M	$6.60M	$4.40M	$34.80M	$6.18M	-

Neurocrine Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (99.12%), and Collaboration Revenue (0.88%).

Neurocrine Biosciences Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
NBIX	Neurocrine Biosciences	$1.89B	$622.10M
ALKS	Alkermes	$1.66B	$378.14M
PBH	Prestige Consumer Healthcare	$1.13B	$283.55M
EVO	Evotec SE	$781.43M	$208.73M
PCRX	Pacira BioSciences	$674.98M	$168.57M
SUPN	Supernus Pharmaceuticals	$607.52M	$175.69M
AMPH	Amphastar Pharmaceuticals	$593.24M	$188.82M
COLL	Collegium Pharmaceutical	$566.77M	$159.30M
ANIP	ANI Pharmaceuticals	$486.82M	$148.33M
ITCI	Intra-Cellular Therapies	$462.18M	$175.38M
IRWD	Ironwood Pharmaceuticals	$442.74M	$91.59M
DVAX	Dynavax	$232.28M	$79.34M
AVDL	Avadel Pharmaceuticals	$27.96M	$50.02M

NBIX Revenue FAQ

What is Neurocrine Biosciences’s yearly revenue?

Neurocrine Biosciences's yearly revenue for 2023 was $1.89B, representing an increase of 26.76% compared to 2022. The company's yearly revenue for 2022 was $1.49B, representing an increase of 31.34% compared to 2021. NBIX's yearly revenue for 2021 was $1.13B, representing an increase of 8.38% compared to 2020.

What is Neurocrine Biosciences’s quarterly revenue?

Neurocrine Biosciences's quarterly revenue for Q3 2024 was $622.1M, a 5.40% increase from the previous quarter (Q2 2024), and a 24.72% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $590.2M, a 14.54% increase from the previous quarter (Q1 2024), and a 30.37% increase year-over-year (Q2 2023). NBIX's quarterly revenue for Q1 2024 was $515.3M, a 0.02% increase from the previous quarter (Q4 2023), and a 22.57% increase year-over-year (Q1 2023).

What is Neurocrine Biosciences’s revenue growth rate?

Neurocrine Biosciences's revenue growth rate for the last 3 years (2021-2023) was 66.48%, and for the last 5 years (2019-2023) was 139.45%.

What are Neurocrine Biosciences’s revenue streams?

Neurocrine Biosciences's revenue streams in c 23 are Product, and Collaboration Revenue. Product generated $1.86B in revenue, accounting 98.60% of the company's total revenue, up 29.13% year-over-year. Collaboration Revenue generated $26.5M in revenue, accounting 1.40% of the company's total revenue, down -44.56% year-over-year.

What is Neurocrine Biosciences’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Neurocrine Biosciences was Product. This segment made a revenue of $1.86B, representing 98.60% of the company's total revenue.